Esra Hatipoğlu

440 total citations
40 papers, 311 citations indexed

About

Esra Hatipoğlu is a scholar working on Endocrinology, Diabetes and Metabolism, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Esra Hatipoğlu has authored 40 papers receiving a total of 311 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Pathology and Forensic Medicine and 8 papers in Surgery. Recurrent topics in Esra Hatipoğlu's work include Pituitary Gland Disorders and Treatments (23 papers), Growth Hormone and Insulin-like Growth Factors (9 papers) and Ophthalmology and Eye Disorders (8 papers). Esra Hatipoğlu is often cited by papers focused on Pituitary Gland Disorders and Treatments (23 papers), Growth Hormone and Insulin-like Growth Factors (9 papers) and Ophthalmology and Eye Disorders (8 papers). Esra Hatipoğlu collaborates with scholars based in Türkiye, Antigua and Barbuda and Cambodia. Esra Hatipoğlu's co-authors include Pınar Kadıoğlu, Ö. Çelik, Abdullah Tüten, Sadi Gündoğdu, Hasan Birol Çotuk, Sezai Şahmay, Mahmut Öncül, Abdullah Serdar Açıkgöz, Süleyman Engin Akhan and Barış Kaya and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Radiation Oncology*Biology*Physics and British Journal of Ophthalmology.

In The Last Decade

Esra Hatipoğlu

33 papers receiving 307 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Esra Hatipoğlu Türkiye 12 199 59 55 39 34 40 311
Rıfki Üçler Türkiye 10 123 0.6× 81 1.4× 56 1.0× 22 0.6× 33 1.0× 39 308
Şefika Burçak Polat Türkiye 13 177 0.9× 116 2.0× 39 0.7× 16 0.4× 28 0.8× 42 363
Nilusha Manji United Kingdom 4 508 2.6× 62 1.1× 141 2.6× 10 0.3× 62 1.8× 6 721
Cüneyd Anıl Türkiye 12 542 2.7× 182 3.1× 52 0.9× 28 0.7× 77 2.3× 30 666
L Levin United States 10 68 0.3× 85 1.4× 162 2.9× 53 1.4× 29 0.9× 18 432
Th. Kaltsas Greece 9 390 2.0× 52 0.9× 180 3.3× 113 2.9× 50 1.5× 11 578
Elżbieta Andrysiak­‍-Mamos Poland 10 108 0.5× 54 0.9× 29 0.5× 19 0.5× 40 1.2× 40 219
Kenichi Sekiya Japan 8 265 1.3× 21 0.4× 69 1.3× 11 0.3× 30 0.9× 15 353
Silvia Perrino Italy 9 284 1.4× 21 0.4× 65 1.2× 42 1.1× 28 0.8× 10 444

Countries citing papers authored by Esra Hatipoğlu

Since Specialization
Citations

This map shows the geographic impact of Esra Hatipoğlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esra Hatipoğlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esra Hatipoğlu more than expected).

Fields of papers citing papers by Esra Hatipoğlu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esra Hatipoğlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esra Hatipoğlu. The network helps show where Esra Hatipoğlu may publish in the future.

Co-authorship network of co-authors of Esra Hatipoğlu

This figure shows the co-authorship network connecting the top 25 collaborators of Esra Hatipoğlu. A scholar is included among the top collaborators of Esra Hatipoğlu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esra Hatipoğlu. Esra Hatipoğlu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Koçak, Burak, Sema Çiftçi Doğanşen, Feyza Yener Öztürk, et al.. (2024). Lateralization outcomes of bilateral inferior petrosal sinus sampling: desmopressin vs CRH. HORMONES. 24(2). 551–559.
2.
Ertan, Yeşim, Esra Hatipoğlu, Cenk Eraslan, et al.. (2024). Distinguishing Pituitary Metastasis and Pituitary Neuroendocrine Tumors through Conventional MR Imaging and Clinical Features. American Journal of Neuroradiology. 45(8). 1063–1069. 1 indexed citations
3.
Doğanşen, Sema Çiftçi, et al.. (2024). Medium and Long-Term Data from a Series of 96 Endoscopic Transsphenoidal Surgeries for Cushing Disease. Journal of Korean Neurosurgical Society. 67(2). 237–248. 1 indexed citations
4.
Erdim, Çağrı, et al.. (2024). Visual recovery following pituitary adenoma surgery: prognostic value of optical coherence tomography and suprasellar tumour volume. Canadian Journal of Ophthalmology. 60(3). 163–169.
5.
Hatipoğlu, Esra, et al.. (2022). Do neurosteroids have impact on depression and cognitive functions in cases with acromegaly?. Growth Hormone & IGF Research. 66. 101496–101496. 5 indexed citations
6.
Üstündağ, Sedat, et al.. (2017). The relationship between mean platelet volume and neutrophil/lymphocyte ratio with inflammation and proteinuria in chronic kidney disease. Saudi Journal of Kidney Diseases and Transplantation. 28(1). 90–90. 24 indexed citations
7.
8.
Keskin, Fatma Ela, Hande Mefkure Özkaya, Nurperi Gazioğlu, et al.. (2015). The problem of unrecognized acromegaly: surgeries patients undergo prior to diagnosis of acromegaly. Journal of Endocrinological Investigation. 38(6). 695–700. 12 indexed citations
9.
Çelik, Ö., Süleyman Engin Akhan, Esra Hatipoğlu, & Pınar Kadıoğlu. (2014). Increased incidence of pelvic organ prolapse in women with acromegaly. European Journal of Obstetrics & Gynecology and Reproductive Biology. 183. 44–47. 1 indexed citations
10.
Hatipoğlu, Esra, et al.. (2014). Corneal endothelial cell density and morphology in patients with acromegaly. Growth Hormone & IGF Research. 24(6). 260–263. 8 indexed citations
11.
Uygunoğlu, Uğur, Ayşegül Gündüz, Esra Hatipoğlu, et al.. (2014). Cerebrotendinous Xanthomatosis: The Effectiveness of High-Dose Piracetam for the Treatment of Cerebellar and Sensorial Ataxia. The Cerebellum. 13(6). 787–790. 3 indexed citations
12.
Tüten, Abdullah, Esra Hatipoğlu, Mahmut Öncül, et al.. (2014). Evaluation of ovarian reserve in Hashimoto's thyroiditis. Gynecological Endocrinology. 30(10). 708–711. 35 indexed citations
13.
Tanrıöver, Necmettin, et al.. (2014). Pituitary stone: a case report and review of the literature. Turkish Neurosurgery. 24(6). 967–73. 7 indexed citations
14.
Hatipoğlu, Esra, et al.. (2014). Discontinuation of somatostatin analogs while acromegaly is in long-term remission. Pituitary. 18(4). 554–560. 13 indexed citations
15.
Hatipoğlu, Esra, Mehmet Yürüyen, Hakan Yavuzer, et al.. (2014). Acromegaly and aging: A comparative cross-sectional study. Growth Hormone & IGF Research. 25(1). 47–52. 15 indexed citations
16.
Hatipoğlu, Esra, et al.. (2013). Impact of treatment satisfaction on quality of life of patients with acromegaly. Pituitary. 17(6). 557–563. 33 indexed citations
17.
İlkova, Hasan, et al.. (2011). The Relation of Changes in Prescribing Patterns of Anti-diabetic Drugs and HbA1c Levels Among Patients with Type 2 Diabetes Mellitus: Systematic Analysis of Studies From the the Past 20 Years in Turkey. SHILAP Revista de lepidopterología. 1 indexed citations
18.
Özkan, Hasan, Ö. Çelik, Esra Hatipoğlu, Fatih Kantarcı, & Pınar Kadıoğlu. (2011). Procalcitonin can be used as a marker of premature atherosclerosis in acromegaly. Pituitary. 15(3). 358–364. 13 indexed citations
19.
Hatipoğlu, Esra, et al.. (2010). Ladik-Hamamayağı (Samsun) sıcak ve soğuk su kaynaklarının hidrojeokimyası ve kökensel yorumu. 31(2). 111–126. 1 indexed citations
20.
Hatipoğlu, Esra, et al.. (2008). Atypical M-Protein Localization in Protein Electrophoresis in a Patient With Multiple Myeloma. Balkan Medical Journal. 2008(1).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rıfki Üçler Breakdown of academic impact, for papers by Şefika Burçak Polat Breakdown of academic impact, for papers by Nilusha Manji Breakdown of academic impact, for papers by Cüneyd Anıl Breakdown of academic impact, for papers by L Levin Breakdown of academic impact, for papers by Th. Kaltsas Breakdown of academic impact, for papers by Elżbieta Andrysiak­‍-Mamos Breakdown of academic impact, for papers by Kenichi Sekiya Breakdown of academic impact, for papers by Silvia Perrino
Rankless by CCL
2026